[Answered] An ABAB design is preferred to a multiple-baseline design if the treatment is expected to have a ...

This topic contains a solution. Click here to go to the answer

Author Question: An ABAB design is preferred to a multiple-baseline design if the treatment is expected to have a ... (Read 234 times)

APUS57

Hero Member
Posts: 571

on: Jun 19, 2018

An ABAB design is preferred to a multiple-baseline design if the treatment is expected to have a permanent or long lasting effect.

a. True
b. False
Indicate whether the statement is true or false

Question 2

Titles for research papers are typically limited to 50 words.

a. True
b. False
Indicate whether the statement is true or false

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

Heffejeff

Sr. Member
Posts: 336

Reply #1 on: Jun 19, 2018

Answer to Question 1

False

Answer to Question 2

False

APUS57

Member
Posts: 571

Reply 2 on: Jun 19, 2018

Gracias!

bitingbit

Member
Posts: 323

Reply 3 on: Yesterday

Thanks for the timely response, appreciate it

« previous next »

Did you know?

Eat fiber! A diet high in fiber can help lower cholesterol levels by as much as 10%.

Did you know?

A serious new warning has been established for pregnant women against taking ACE inhibitors during pregnancy. In the study, the risk of major birth defects in children whose mothers took ACE inhibitors during the first trimester was nearly three times higher than in children whose mothers didn't take ACE inhibitors. Physicians can prescribe alternative medications for pregnant women who have symptoms of high blood pressure.

Did you know?

Throughout history, plants containing cardiac steroids have been used as heart drugs and as poisons (e.g., in arrows used in combat), emetics, and diuretics.

Did you know?

Nitroglycerin is used to alleviate various heart-related conditions, and it is also the chief component of dynamite (but mixed in a solid clay base to stabilize it).

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.